Literature DB >> 19299000

Human papillomavirus profile of women in Belize City, Belize: correlation with cervical cytopathologic findings.

Helen P Cathro1, Theresa Loya, Frederick Dominguez, Susan L Howe, Renee Howell, Kyle Orndorff, Jessica Moreno, Elena Mendez, Po Chu Fung, Natalie L Beer, Peter Allen, Alba M Sosa, Kelly K Gurka, Mark H Stoler, Henry F Frierson.   

Abstract

Cervical carcinoma is the most common cancer among Belizean women; however, data regarding the frequency of human papillomavirus (HPV) genotypes and their association with cervical cancer are nonexistent. We therefore included HPV genotyping as part of a week-long cervical cancer screening campaign conducted in Belize City in 2007. Conventional Papanicolaou smears with Hybrid Capture (HC) 2 HPV testing were performed on 463 women. All HC2-positive samples were genotyped using a developmental GP5+/GP6+ polymerase chain reaction-coupled Luminex assay for 2 low-risk and 18 high-risk HPV types. The prevalence of high-risk HPV was 15.6% in the total population, 10.1% in those with normal cytologic findings, and 93.3% in women with a high-grade squamous intraepithelial lesion. Of patients with HPV infections, 35% had multiple types (5.4% of the total group). Of all women and of women with normal cytologic findings, 5.2% and 2.8%, respectively, had HPV16 or 18. For all women, HPV16, 18, 56, and 52 were present in decreasing order of frequency. HPV11 was present in only one patient, and none had HPV6. HPV16 was found in 47% of high-grade squamous epithelial lesions; however, no case of HSIL had HPV18 or 45. HPV35 and HPV58 were the next most common types in high-grade squamous intraepithelial lesion, each occurring in 20% of cases of high-grade squamous intraepithelial lesion, followed by HPV31 in 13.3%. Although women younger than 25 years old were underrepresented, these data suggest that the HPV profile of this cohort of Belizean women differs somewhat from that in the region. In addition, these data are of importance with regard to the development of HPV vaccines that will be used in less developed countries, where care should be taken not to implement vaccination at the cost of basic screening and diagnostic services.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19299000     DOI: 10.1016/j.humpath.2008.12.015

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

Review 1.  Type-specific HPV prevalence in cervical cancer and high-grade lesions in Latin America and the Caribbean: systematic review and meta-analysis.

Authors:  Agustín Ciapponi; Ariel Bardach; Demián Glujovsky; Luz Gibbons; María Alejandra Picconi
Journal:  PLoS One       Date:  2011-10-04       Impact factor: 3.240

2.  Statistical Modeling for Quality Assurance of Human Papillomavirus DNA Batch Testing.

Authors:  Emily N Beylerian; Rose C Slavkovsky; Francesca M Holme; Jose A Jeronimo
Journal:  J Low Genit Tract Dis       Date:  2018-07       Impact factor: 1.925

3.  Prevalence of high-risk human papillomavirus among women in two English-speaking Caribbean countries.

Authors:  Glennis Andall-Brereton; Eulynis Brown; Sherian Slater; Yvette Holder; Silvana Luciani; Merle Lewis; Beryl Irons
Journal:  Rev Panam Salud Publica       Date:  2017-06-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.